784 related articles for article (PubMed ID: 18162985)
1. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
2. Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis.
Ishikawa A; Itoh M; Ushlyama T; Suzuki K; Fujita K
Clin Transplant; 1998 Apr; 12(2):80-3. PubMed ID: 9575393
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to successful ABO-incompatible high-titer renal transplantation.
Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T
Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
5. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
6. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
[TBL] [Abstract][Full Text] [Related]
7. ABO-incompatible renal transplantation at Tokyo Women's Medical University.
Tanabe K; Tokumoto T; Ishida H; Toma H; Nakajima I; Fuchinoue S; Teraoka S
Clin Transpl; 2003; ():175-81. PubMed ID: 15387109
[TBL] [Abstract][Full Text] [Related]
8. Isoagglutinin adsorption in ABO-incompatible transplantation.
Genberg H; Kumlien G; Wennberg L; Tydén G
Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
[TBL] [Abstract][Full Text] [Related]
9. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.
Sawada T; Fuchinoue S; Kawase T; Kubota K; Teraoka S
Clin Transplant; 2004 Jun; 18(3):254-60. PubMed ID: 15142045
[TBL] [Abstract][Full Text] [Related]
10. Immunization by blood-type antigen in human immunoglobulin products before ABO-incompatible kidney transplantation.
Sawada T; Ando T; Sato S; Kubota K; Fuchinoue S; Teraoka S
Clin Transplant; 2004 Apr; 18(2):219-21. PubMed ID: 15016140
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
[TBL] [Abstract][Full Text] [Related]
12. Plasma exchange conditioning for ABO-incompatible renal transplantation.
Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
[TBL] [Abstract][Full Text] [Related]
13. [A case of renal transplantation from an ABO-incompatible donor successfully pretreated with double filtration plasmapheresis].
Hirano Y; Ohira T; Ishikawa A; Ushiyama T; Suzuki K; Fujita K
Hinyokika Kiyo; 1996 Nov; 42(11):887-90. PubMed ID: 8973941
[TBL] [Abstract][Full Text] [Related]
14. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
[TBL] [Abstract][Full Text] [Related]
15. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
16. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
[TBL] [Abstract][Full Text] [Related]
17. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
19. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
[TBL] [Abstract][Full Text] [Related]
20. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S13-6. PubMed ID: 18162979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
